Chronic opioid use and central sleep apnea: a review of the prevalence, mechanisms, and perioperative considerations.

Correa D, Farney RJ, Chung F, Prasad A, Lam D, Wong J. Chronic opioid use and central sleep apnea: a review of the prevalence, mechanisms, and perioperative considerations. Anesth Analg. 2015;120(6):1273-85. DOI: 10.1213/ANE.0000000000000672. PubMed PMID: 25988636.

Polypharmacy in the Aging Patient: A Review of Glycemic Control in Older Adults With Type 2 Diabetes.

Lipska KJ, Krumholz H, Soones T, Lee SJ. Polypharmacy in the Aging Patient: A Review of Glycemic Control in Older Adults With Type 2 Diabetes. JAMA. 2016;315(10):1034-45. DOI: 10.1001/jama.2016.0299. PubMed PMID: 26954412.

Anticholinergic effects of medication in elderly patients.

Tune LE. Anticholinergic effects of medication in elderly patients. J Clin Psychiatry. 2001;62 Suppl 21:11-4. PubMed PMID: 11584981.

Physical and cognitive performance and burden of anticholinergics, sedatives, and ACE inhibitors in older women.

Cao Y-J, Mager DE, Simonsick EM, Hilmer SN, Ling SM, Windham BG, et al. Physical and cognitive performance and burden of anticholinergics, sedatives, and ACE inhibitors in older women. Clin Pharmacol Ther. 2008;83(3):422-9. DOI: 10.1038/sj.clpt.6100303. PubMed PMID: 17713474.

Latent classes of polysubstance use among adolescents-a systematic review.

Tomczyk S, Isensee B, Hanewinkel R. Latent classes of polysubstance use among adolescents-a systematic review. Drug Alcohol Depend. 2016;160:12-29. DOI: 10.1016/j.drugalcdep.2015.11.035. PubMed PMID: 26794683.

Health outcomes associated with potentially inappropriate medication use in older adults.

Fick DM, Mion LC, Beers MH, Waller JL. Health outcomes associated with potentially inappropriate medication use in older adults. Res. Nurs. Health. 2008;31(1):42-51. DOI: 10.1002/nur.20232. PubMed PMID: 18163447; PubMed Central PMCID: PMC2247370.

Psychotropic prescribing in seriously violent men with schizophrenia or personality disorder in a UK high security hospital.

Stone-Brown K, Naji M, Francioni A, Myers K, Samarendra H, Mushtaq-Chaudhry H, et al. Psychotropic prescribing in seriously violent men with schizophrenia or personality disorder in a UK high security hospital. CNS Spectr. 2016;21(1):60-9. DOI: 10.1017/S1092852915000784. PubMed PMID: 26726766.

Medication Regimen Complexity and Polypharmacy as Factors Associated With All-Cause Mortality in Older People: A Population-Based Cohort Study.

Wimmer BC, Bell JS, Fastbom J, Wiese MD, Johnell K. Medication Regimen Complexity and Polypharmacy as Factors Associated With All-Cause Mortality in Older People: A Population-Based Cohort Study. Ann Pharmacother. 2016;50(2):89-95. DOI: 10.1177/1060028015621071. PubMed PMID: 26681444.

Psychopharmacological treatment of 2195 in-patients with borderline personality disorder: A comparison with other psychiatric disorders.

Bridler R, Häberle A, Müller ST, Cattapan K, Grohmann R, Toto S, et al.. Psychopharmacological treatment of 2195 in-patients with borderline personality disorder: A comparison with other psychiatric disorders. European Neuropsychopharmacol. 2015;25(6):763-72. DOI: 10.1016/j.euroneuro.2015.03.017. PubMed PMID: 25907249.

A naturalistic study of changes in pharmacological prescription for borderline personality disorder in clinical practice: from APA to NICE guidelines.

Pascual JC, Martín-Blanco A, Soler J, Ferrer A, Tiana T, Alvarez E, et al.. A naturalistic study of changes in pharmacological prescription for borderline personality disorder in clinical practice: from APA to NICE guidelines. Int Clin Psychopharmacol. 2010;25(6):349-55. DOI: 10.1097/YIC.0b013e32833e23ed. PubMed PMID: 20838221.